Hubalek, M., Brantner, C., & Marth, C. (2012). Role of pertuzumab in the treatment of HER2-positive breast cancer. Dove Medical Press.
Style de citation ChicagoHubalek, Michael, Christine Brantner, et Christian Marth. Role of Pertuzumab in the Treatment of HER2-positive Breast Cancer. Dove Medical Press, 2012.
Style de citation MLAHubalek, Michael, Christine Brantner, et Christian Marth. Role of Pertuzumab in the Treatment of HER2-positive Breast Cancer. Dove Medical Press, 2012.
Attention : ces citations peuvent ne pas être correctes à 100%.